119 related articles for article (PubMed ID: 24288736)
21. [Kinetics of regression and relapse of Walker carcinosarcoma treated with alkylating agents].
Parkanskiĭ MN; Konovalova NP; Emanuél' N
Izv Akad Nauk SSSR Biol; 1973; (1):144-6. PubMed ID: 4218850
[No Abstract] [Full Text] [Related]
22. Lymphocyte migration during the development of regional lymph node anergy in experimental tumor growth.
Kimpton WG; McKenzie GA; Muller HK; Ruby JC; Poskitt DC
Cell Immunol; 1983 Jan; 75(1):13-21. PubMed ID: 6825181
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effect of laticifer proteins of Himatanthus drasticus (Mart.) Plumel - Apocynaceae.
Mousinho KC; Oliveira Cde C; Ferreira JR; Carvalho AA; Magalhães HI; Bezerra DP; Alves AP; Costa-Lotufo LV; Pessoa C; de Matos MP; Ramos MV; Moraes MO
J Ethnopharmacol; 2011 Sep; 137(1):421-6. PubMed ID: 21679758
[TBL] [Abstract][Full Text] [Related]
24. Effects of tumor necrosis factor alpha on skeletal muscle and Walker 256 carcinosarcoma protein metabolism studied in vivo.
Tayek JA; Brasel JA
Cancer Res; 1990 May; 50(9):2765-8. PubMed ID: 2328503
[TBL] [Abstract][Full Text] [Related]
25. [Kinetic study of the reaction of regional lymph nodes and the spleen to the growth of Walker carcinosarcoma].
Volodarskaia TA; Erokhin VN
Izv Akad Nauk SSSR Biol; 1974; (2):289-94. PubMed ID: 4461751
[No Abstract] [Full Text] [Related]
26. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
Norpoth K; Witting U; Rauen HM
Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
[No Abstract] [Full Text] [Related]
27. [Studies on the solid Walker-carcinosarcoma 256 in the rat during administration of cytostatics].
Mattern J; Volm M; Wayss K
Arzneimittelforschung; 1972 Oct; 22(10):1721-2. PubMed ID: 4677063
[No Abstract] [Full Text] [Related]
28. [Antitumor activity of CPT-11 against rat Walker 256 carcinoma].
Furuta T; Yokokura T; Mutai M
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2757-60. PubMed ID: 3415271
[TBL] [Abstract][Full Text] [Related]
29. Effects of guinea-pig serum on the Walker 256 carcinosarcoma.
Dolowy WC; Schrek R; Henson D; Cornet J; Brown E
Nature; 1968 Jun; 218(5146):1028-31. PubMed ID: 5656616
[No Abstract] [Full Text] [Related]
30. Augmentation of the effect of doxorubicin with low-dose tumor necrosis factor in experimental liver metastasis.
Bloom ND; Norbergs DA; Sherman B; Sadjadi M; Ramaswamy G; Jacobs R; Ackerman N
Mol Biother; 1990 Jun; 2(2):121-4. PubMed ID: 2363856
[TBL] [Abstract][Full Text] [Related]
31. Suppression of angiogenesis by the antitumor agent titanocene dichloride.
Bastaki M; Missirlis E; Klouras N; Karakiulakis G; Maragoudakis ME
Eur J Pharmacol; 1994 Jan; 251(2-3):263-9. PubMed ID: 7512041
[TBL] [Abstract][Full Text] [Related]
32. A pilot study of antitumor effect of gallium ethylenediaminetetramethylene phosphonate [Ga(III)-EDTMP] in tumor-bearing rats.
Su M; Qiu Y; Jia W
Adv Ther; 2005; 22(4):297-306. PubMed ID: 16418139
[TBL] [Abstract][Full Text] [Related]
33. [Behaviour of clostridial antibodies in rats with transplantable tumours under therapy by cyclophosphamide (author's transl)].
Kretschmer H; Hambsch K; Ludewig R
Arch Geschwulstforsch; 1974; 44(2):103-5. PubMed ID: 4471604
[No Abstract] [Full Text] [Related]
34. [Ultrastructural changes in endothelial cells of blood capillaries of the Walker 256 carcinosarcoma while treated with melatonin].
Ovsianko EV; Pustovetova MG; Samsonova EN; Ovsianko IaU; Fedina RG; Kulishenko AO; Vinogradov AS
Vopr Onkol; 2014; 60(2):80-3. PubMed ID: 24919267
[TBL] [Abstract][Full Text] [Related]
35. Response of intramuscular Walker 256 rat tumor to sustained-release cyclophosphamide and ARA-C capsules.
Fu JC; Moyer DL; Cuevas J; Cummings L; Eaton A; Elshire D
J Surg Oncol; 1978; 10(2):133-40. PubMed ID: 642513
[TBL] [Abstract][Full Text] [Related]
36. Potentiated cyclophosphane: experimental study of the effect on tumor development and efficiency of cytostatic therapy.
Amosova EN; Zueva EP; Razina TG; Krylova SG; Shilova NV; Epstein OI
Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():107-10. PubMed ID: 12949669
[TBL] [Abstract][Full Text] [Related]
37. Effect of radiation plus endotoxin on the Walker 256 rat carcinosarcoma.
De los Angeles Contre
Proc Soc Exp Biol Med; 1967 Mar; 124(3):948-53. PubMed ID: 6023438
[No Abstract] [Full Text] [Related]
38. Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats.
Chekhun VF; Storchai DM; Todor IN; Borikun TV; Lukianova NY
Exp Oncol; 2018 Oct; 40(3):200-204. PubMed ID: 30284996
[TBL] [Abstract][Full Text] [Related]
39. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
Keller HJ; Keppler B; Schmähl D
Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
[TBL] [Abstract][Full Text] [Related]
40. [Change in the content of lipid-soluble antioxidants in animals with Walker-256 carcinosarcoma exposed to different therapies].
Patol Fiziol Eksp Ter; 2009; (3):27-9. PubMed ID: 19919013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
